Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Roel Bulthuis - Director at NMD Pharma | The Org
NMD Pharma — NMD Pharma
Investors — NMD Pharma
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis | MENAFN.COM
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Detailed Description | NMD-GPS
NMD Pharma company information, funding & investors | Dealroom.co
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma
NMD Pharma
Management — NMD Pharma
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders | Nordic 9
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma - Capnova
NMD Pharma company information, funding & investors | Dealroom.co
Big deal: NMD flexes series A muscles - Global University Venturing
